Physician profile
David Osborn
NPI 1841413275
$6,210.38
in general payments reported to CMS, 2019-2025
43 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.95 · 2020: $16.36 · 2021: $384 · 2022: $1,659 · 2023: $1,225 · 2024: $1,770 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,137.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $786.49 | 2021-2025 | |
| Teleflex LLC | $625.33 | 2021-2025 | Urolift |
| Astellas Pharma US INC | $439.12 | 2021-2025 | Myrbetriq, Xtandi, Veozah |
| Axonics, INC. | $338.30 | 2022-2024 | Axonics |
| Urogen Pharma, INC. | $319.04 | 2021-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $267.55 | 2019-2024 | Aveed, Xiaflex, Edex |
| Boston Scientific Corporation | $254.78 | 2024-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter |
| Urovant Sciences INC | $231.82 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $229.94 | 2022-2025 | Pylarify |
| Antares Pharma, INC. | $212.94 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $189.41 | 2023-2025 | Orgovyx, Gemtesa |
| Ferring Pharmaceuticals INC. | $184.51 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $176.56 | 2022-2025 | Erleada, Stelara, Tremfya |
| Bayer Healthcare Pharmaceuticals INC. | $174.64 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $150.83 | 2021-2025 | Keytruda, Lynparza, Welireg |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $131.55 | 2025 | Erleada |
| Endo USA, INC. | $126.82 | 2024-2025 | Aveed, Xiaflex, Edex |
| Allergan, INC. | $122.06 | 2021-2022 | |
| Medtronic, INC. | $112.29 | 2022-2023 | Interstim |
| Novartis Pharmaceuticals Corporation | $104.26 | 2023-2025 | |
| Coloplast Corp | $101.04 | 2021-2024 | |
| Abbott Laboratories | $91.44 | 2024 | Proclaim |
| Blue Earth Diagnostics | $89.36 | 2021-2023 | |
| Pfizer INC. | $88.61 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $68.57 | 2022-2023 | Provenge |
| Telix Pharmaceuticals | $65.36 | 2024-2025 | Illuccix |
| Myriad Genetic Laboratories, INC. | $59.94 | 2023-2024 | Prolaris |
| Tolmar, INC. | $48.03 | 2023-2024 | |
| Biotissue Holdings INC. | $44.69 | 2022 | |
| Halozyme INC | $43.82 | 2023 | |
| Acerus Pharmaceuticals Corporation | $34.34 | 2022 | |
| Caris Mpi, INC. | $31.35 | 2025 | Mi Cancer Seek |
| Tempus Ai, INC | $29.26 | 2025 | Xt Cdx |
| Lantheus Medical Imaging, INC. | $28.85 | 2024 | |
| Immunitybio, INC. | $28.50 | 2025 | |
| 180 Medical, INC. | $27.56 | 2021 | |
| Myovant Sciences INC. | $26.21 | 2022 | |
| Civco Medical Instruments | $25.68 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $22.68 | 2021 | |
| Accord Healthcare, INC. | $22.20 | 2024 | |
| Olympus America INC. | $19.64 | 2024 | Itind System |
| Bluewind Medical | $17.66 | 2025 | Revi |
| Amgen INC. | $17.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Osborn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.